Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10404)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2016 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sinn M, Bahra M, Denecke T, Travis S, Pelzer U, Riess H. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival. World J Gastrointest Oncol 2016; 8(3): 248-257 [PMID: 26989460 DOI: 10.4251/wjgo.v8.i3.248] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i3/248.htm |
| Number | Citing Articles |
| 1 |
Yu. I. Patyutko, A. G. Kotelnikov, A. N. Polyakov, V. D. Podluzhnyi. Evolution of surgery for pancreatic head and periampullary cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3): 45 doi: 10.16931/1995-5464.2019345-53
|
| 2 |
Run-Cong Nie, Xue-Bin Zou, Shu-Qiang Yuan, Ying-Bo Chen, Shi Chen, Yong-Ming Chen, Guo-Ming Chen, Xiao-Jiang Chen, Tian-Qi Luo, Shu-Man Li, Jin-Ling Duan, Yun Wang, Yuan-Fang Li. Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06910-5
|
| 3 |
Wei Jing, Na Song, Yunpeng Liu, Xiujuan Qu, Kezuo Hou, Xianghong Yang, Xiaofang Che. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7923
|
| 4 |
Daniel H. Palmer, Juan W. Valle, Yuk Ting Ma, Olusola Faluyi, John P. Neoptolemos, Trine Jensen Gjertsen, Berit Iversen, Jon Amund Eriksen, Anne-Sophie Møller, Anne-Kirsti Aksnes, Robert Miller, Svein Dueland. TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial. British Journal of Cancer 2020; 122(7): 971 doi: 10.1038/s41416-020-0752-7
|
| 5 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 6 |
V. M. Kopchak, M. V. Kostyliev, L. O. Pererva, O. V. Duvalko, V. V. Khanenko, H. H. Shevkolenko, S. V. Andronik, V. I. Trachuk. Хірургічне лікуваннях хворих із місцеворозповсюдженими пухлинами підшлункової залози. Шпитальна хірургія. Журнал імені Л. Я. Ковальчука 2020; (1): 51 doi: 10.11603/2414-4533.2020.1.10737
|
| 7 |
Alicia Eubanks, Julie Pepe, Paula Veldhuis, Sebastian G. de la Fuente. Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer. Journal of Geriatric Oncology 2018; 9(4): 362 doi: 10.1016/j.jgo.2017.12.004
|
| 8 |
Ramesh B. Batchu, Oksana V. Gruzdyn, Pavan S. Tavva, Bala K. Kolli, Rajesh Dachepalli, Donald W. Weaver, Scott A. Gruber. Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer. Surgery 2019; 166(4): 503 doi: 10.1016/j.surg.2019.05.047
|
| 9 |
Ramesh B. Batchu, Oksana V. Gruzdyn, Ebrahem M. Mahmud, Fatme Chukr, Rajesh Dachepalli, Santosh K. Manmari, Gamal Mostafa, Donald W. Weaver, Scott A. Gruber. Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell activity in pancreatic cancer in vitro. Surgery 2018; 163(3): 627 doi: 10.1016/j.surg.2017.10.056
|
| 10 |
Alexandra G. Lopez-Aguiar, Shishir K. Maithel. Current and Emerging Therapies in Pancreatic Cancer. 2018; : 349 doi: 10.1007/978-3-319-58256-6_19
|
| 11 |
Elzbieta Nowara, Joanna Huszno. Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1. Expert Review of Precision Medicine and Drug Development 2016; 1(6): 479 doi: 10.1080/23808993.2016.1257911
|
| 12 |
A. A. Shabunin, A. A. Karpov, E. V. Kizhaev, V. V. Bedin, M. M. Tavobilov, O. V. Paklina, G. R. Setdikova. Combined surgical treatment of pancreatic head cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(3): 8 doi: 10.16931/1995-5464.201838-13
|
| 13 |
Marianne Sinn, Marcus Bahra, Torsten Liersch, Klaus Gellert, Helmut Messmann, Wolf Bechstein, Dirk Waldschmidt, Lutz Jacobasch, Martin Wilhelm, Bettina M. Rau, Robert Grützmann, Arndt Weinmann, Georg Maschmeyer, Uwe Pelzer, Jens M. Stieler, Jana K. Striefler, Michael Ghadimi, Sven Bischoff, Bernd Dörken, Helmut Oettle, Hanno Riess. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial. Journal of Clinical Oncology 2017; 35(29): 3330 doi: 10.1200/JCO.2017.72.6463
|
| 14 |
Meng Lu, Chun‑Hui Yuan, Ling‑Fu Zhang, Lian‑Yuan Tao, Ying Peng, Li‑Mei Guo, Gang Li, Dian‑Rong Xiu. Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10269
|
| 15 |
Yue Zhao, Jiahui Li, Dai Li, Zhefang Wang, Jiangang Zhao, Xiaolin Wu, Qiye Sun, Peter Ping Lin, Patrick Plum, Alexander Damanakis, Florian Gebauer, Menglong Zhou, Zhen Zhang, Hans Schlösser, Karl-Walter Jauch, Peter J. Nelson, Christiane J. Bruns. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers. Seminars in Cancer Biology 2020; 60: 334 doi: 10.1016/j.semcancer.2019.08.026
|
| 16 |
Kexin Li, Qingji Huo, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Sungsoo Na, Melissa L. Fishel, Bai-Yan Li, Hiroki Yokota. Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(20): 4917 doi: 10.3390/cancers15204917
|
| 17 |
Abdelkader Taibi, Jeremie Jacques, Sylvaine Durand Fontanier, Aurelie Charissoux, Sylvia M. Bardet, Niki Christou, Fabien Fredon, Denis Valleix, Muriel Mathonnet. Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review. Clinical Case Reports 2019; 7(11): 2092 doi: 10.1002/ccr3.2429
|
| 18 |
Marcus Bahra. Operative Therapie distaler Cholangiokarzinome. Der Chirurg 2021; 92(9): 788 doi: 10.1007/s00104-021-01453-2
|